Identification of RAPGEF3 as the therapeutic vulnerability of basal-subtype lung squamous cell carcinoma. Zhou Y, Wang H, Tang S, He Y, et al. Oncogene 2025;44:3142-3148.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhou Y, Wang H, Tang S, He Y, et al. Identification of RAPGEF3 as the therapeutic vulnerability of basal-subtype lung squamous cell carcinoma. Oncogene 2025;44:3142-3148.
PMID: 40781157